Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

NB Power should operate independently without political interference, review says

March 30, 2026

Carney says forced labour a ‘global issue,’ ‘parts of China’ at higher risk

March 30, 2026

Aluminum Association Responds to Attacks on Gulf Industry Infrastructure

March 30, 2026

Priority Ambulance Promotes Robin Tinberg to Assistant Chief Revenue Officer

March 30, 2026

P.E.I. to become first province to lower colorectal cancer screening age to 45

March 30, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Nordic Naturals Issues Voluntary Recall of Baby’s Vitamin D3 Liquid Due to Elevated Levels of Vitamin D3
Press Release

Nordic Naturals Issues Voluntary Recall of Baby’s Vitamin D3 Liquid Due to Elevated Levels of Vitamin D3

By News RoomFebruary 17, 20242 Mins Read
Nordic Naturals Issues Voluntary Recall of Baby’s Vitamin D3 Liquid Due to Elevated Levels of Vitamin D3
Share
Facebook Twitter LinkedIn Pinterest Email

WATSONVILLE, Calif., Feb. 17, 2024 (GLOBE NEWSWIRE) — Nordic Naturals is voluntarily recalling one lot of Nordic Naturals Baby’s Vitamin D3 Liquid, 0.76 fl. oz. (22.5 mL), 400 IU (10mcg) D3. This recall is being conducted due to a manufacturing error that resulted in an elevated level of Vitamin D3 dosage or super potent dose. The affected lot number is 234909, with an expiration date of December 2025.

Prolonged use of the recalled Baby’s Vitamin D3 Liquid could potentially lead to elevated vitamin D levels, resulting in vomiting, loss of appetite, increased thirst, frequent urination, and inability to thrive in infants.

Nordic Naturals has taken immediate action by notifying distributors, retailers and customers directly via email and arranging for the return of all recalled products. The affected product is used as a dietary supplement for infants up to 12 months of age and is packaged in boxes containing one bottle and one dropper for dosage, under SKU RUS-02733.

Nordic Naturals

Consumers, distributors, and retailers in possession of the recalled product should discontinue use immediately and return it to the place of purchase for a refund or replacement. The lot number can be found on the back of the box and on the bottle.

Approximately 3,800 units of product were affected, with one-fifth already returned by retailers. The reason for the recall is solely due to an isolated manufacturing error. There have been no reports of adverse events to date related to the use of this recalled product.

If infants experience any of these symptoms while using the product, report them to the FDA’s MedWatch Adverse Event Reporting program online at www.fda.gov/medwatch/report.htm. Nordic Naturals can also be contacted directly at [email protected] or 888-294-7440, Monday – Friday, 8:00 a.m. – 5:00 p.m. PST. Consumers are advised to consult their physician or healthcare provider if they have experienced any problems related to taking or using this product.

Nordic Naturals prioritizes consumer safety, reaffirming its dedication to quality products. We are swiftly removing the recalled item from the market to safeguard the health and well-being of our customers.

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/5dfda5cd-e755-4ed0-866e-c6e95fdb8073

https://www.globenewswire.com/NewsRoom/AttachmentNg/9aedf188-c741-4237-b79b-8ee6e8225ba9


Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Aluminum Association Responds to Attacks on Gulf Industry Infrastructure

Priority Ambulance Promotes Robin Tinberg to Assistant Chief Revenue Officer

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

Persona AI Announces Brian Davis as Head of Global Manufacturing

Your Call Canada! Kruger Big Assist asks Canadians to choose grand prize minor hockey winner to receive total of $100,000

Atlantic Jet Partners Strengthens MRO Leadership with Steve Takacs Appointment at Sky Aircraft Maintenance

2025 Yuewen Global IP Awards Conclude in Macao, Showcasing China’s IP Industry in the AI Era

Terra Pharm Medical Marijuana Organization Opens Cultivation Facility and Dispensaries in Pennsylvania

Guitarist Bobby Broom Celebrates Jazz Titan (and Mentor) Sonny Rollins With “Notes of Thanks,” Set for May 1 Release by Steele Records

Editors Picks

Carney says forced labour a ‘global issue,’ ‘parts of China’ at higher risk

March 30, 2026

Aluminum Association Responds to Attacks on Gulf Industry Infrastructure

March 30, 2026

Priority Ambulance Promotes Robin Tinberg to Assistant Chief Revenue Officer

March 30, 2026

P.E.I. to become first province to lower colorectal cancer screening age to 45

March 30, 2026

Latest News

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

March 30, 2026

Authorities in Canada warn of fraud as FIFA World Cup approaches

March 30, 2026

Beats’ gym-friendly Powerbeats Fit are $30 off for Amazon’s Big Spring Sale

March 30, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version